Table 33-2.
Clinical and Radiologic Findings in Patients with Human Metapneumovirus (hMPV) Compared with Those with Respiratory Syncytial Virus (RSV)
Percent of Patients with hMPV | Percent of Patients with RSV | |
---|---|---|
Clinical findings | ||
Cough | 72-90 | 76 |
Rhinitis | 80-88 | 72 |
Fever | 52-61 | 48 |
Retractions | 60 | 64 |
Hypoxemia | 47 | 82 |
Anorexia | 33-36 | 76 |
Wheezing | 22-24 | 32 |
Chest radiograph findings | ||
Atelectasis | 40 | 19 |
Hyperinflation | 33 | 44 |
Infiltrate | 33 | 31 |
Bronchial thickening | 0 | 13 |
From Williams JV, Harris PA, Tollefson SJ, et al: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350:443-450, 2004; Mejias A, Chavez-Bueno S, Ramilo O: Human metapneumovirus: A not so new virus. Pediatr Infect Dis J 23:1-10, 2004; and van den Hoogen BG, van Doornum GJJ, Fockens JC, et al: Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188:1571-1577, 2003.
© 2008
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.